Project Grant HT9425261E093
Award Date 7/1/26
Completion Date 6/30/29
Dollars Obligated $1.7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
- Federal Grant Award Summary The University of Michigan's Regents received a $1.84 million Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2028. The award supports research focused on co-targeting NSD1/2 paralogs in androgen receptor (AR)-driven castration-resistant prostate cancer. This research initiative represents a translational oncology effort designed to advance...
- Federal Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects received a $248,156 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period October 1, 2025 through September 30, 2027. The award supports research focused on identifying molecular biomarkers for invasive glioblastoma cell states and tumor microenvironment modulation. This research initiative will be conducted at...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded the Regents of the University of Michigan a $559,046 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period June 1, 2026 through May 31, 2028. The award funds research investigating biased protein phosphatase 2A heterotrimerization in the development and treatment of uveal melanoma. This hypothesis-driven research initiative is expected to advance understanding of...
- Federal Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects has received a $1.396 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2026 through June 30, 2029. The award supports clinical validation of a plasma circulating tumor DNA (ctDNA) assay for diffuse midline glioma (DMG) diagnosis and surveillance. This research initiative contributes to the DHA's...
- The Regents of the University of Michigan received a $2.098 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded June 1, 2026, with an ultimate completion date of May 31, 2030. The award funds research and development activities focused on the development of antibody CBP/P300 degrader conjugates for the treatment of castration-resistant prostate cancer. This research initiative represents a translational...
- Federal Project Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects has been awarded $448,133 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project titled "Targeting Mycobiome Metabolism to Reprogram the Immunosuppressive Pancreatic Tumor Microenvironment." The three-year award, effective November 1, 2025 through October 31, 2028, supports hypothesis-driven biomedical...
- Federal Grant Award Summary The University of Michigan received a $624,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on July 15, 2025, with completion anticipated by July 14, 2027. The award supports research investigating "The Role of Epithelial AIM2 in Helicobacter pylori-Associated Gastric Preneoplasia," conducted at the institution's Ann Arbor, Michigan campus. This research project contributes...
- Federal Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects received a $405,600 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2027. The award supports research on retinal repair via viral-mediated endogenous reprogramming of Müller glia cells, conducted at the University of Michigan's Ann Arbor campus. This research initiative...
- Federal Grant Award Summary The University of Michigan's Regents, through its Office of Research and Sponsored Projects Division, received a $537,536 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective November 1, 2025, through October 31, 2028. The research initiative, titled "Targeting Mycobiome Metabolism to Reprogram the Immunosuppressive Pancreatic Tumor Microenvironment," will be conducted...
- Federal Grant Award Summary The University of Michigan received a $838,945 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2026 through June 30, 2028. The award supports research investigating selective pharmacological cochaperones to address TDP43-dependent disease mechanisms in amyotrophic lateral sclerosis (ALS). This research effort will be conducted at the University of Michigan's Ann Arbor...